An article1 in the September 2003 issue of the ARCHIVES reported on the use of a gel manufactured by Pacer Technology for purposes of “creating a temporary tarsorrhaphy in patients unsuitable for more invasive procedures, for temporary eyelid apposition for persistent epithelial defects, or just for ease of use in the office or at the bedside.”